In addition, it has been shown that the expression of STING is decreased in melanoma and colon cancer29,30 and that decreased levels of STING correlate with poor survival in gastric cancer patients.31 STING downregulation and its consequences in malignant B cells have not been investigated. The gene discussed is STING1; the disease is melanoma.